Engineering mesenchymal stromal cells with neutralizing and anti-inflammatory capability against SARS-CoV-2 infection-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Engineering mesenchymal stromal cells with neutralizing and anti-inflammatory capability against SARS-CoV-2 infection

Published:2021-06 Issue: Volume:21 Page:754-764
ISSN:2329-0501
Container-title:Molecular Therapy - Methods & Clinical Development
language:en
Short-container-title:Molecular Therapy - Methods & Clinical Development

Author:

Zhang Xiaoqing,Han Ping,Wang Haiyong,Xu Yanqin,Li Fanlin,Li Min,Fan Lilv,Zhang Huihui,Dai Qiang,Lin Hao,Qi Xinyue,Liang Jie,Wang Xin,Yang Xuanming

Funder

Shanghai Jiao Tong University

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Genetics,Molecular Biology,Molecular Medicine

Reference66 articles.

1. A pneumonia outbreak associated with a new coronavirus of probable bat origin;Zhou;Nature,2020

2. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus;Li;Nature,2003

3. Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2;Wang;Cell,2020

4. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation;Wrapp;Science,2020

5. Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov;Zhao;bioRxiv,2020

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stem cell-based therapy for COVID-19;International Immunopharmacology;2023-11

2. Early Trends to Show the Efficacy of Cordyceps militaris in Mild to Moderate COVID Inflammation;Cureus;2023-08-18

3. Specific Activation of T Cells by an ACE2-Based CAR-Like Receptor upon Recognition of SARS-CoV-2 Spike Protein;International Journal of Molecular Sciences;2023-04-21

4. Covid-19 prevention and treatment by targeting Fc-fusion proteins: An experience to fight emerging diseases;Current Molecular Medicine;2023-04-10

5. Development and Characterization of Phage-Display-Derived Novel Human Monoclonal Antibodies against the Receptor Binding Domain of SARS-CoV-2;Biomedicines;2022-12-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3